Atlas Trials

Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC

Clinical trial NCT03953443 · COMPLETED

Trial details

NCT number
NCT03953443
Sponsor
New Mexico Cancer Research Alliance
Status
COMPLETED
Study type
OBSERVATIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2010-12-17
Primary completion
2020-02-13
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.